Vegetative pyoderma gangrenosum: This type, also known as superficial pyoderma gangrenosum, causes ulcers that are not particularly deep or painful. It usually develops in people with no ...

A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, delaying treatment and leading to inappropriate interventions ...

“A MID of 7-day pain scores for pyoderma gangrenosum was a 2-point improvement on an NRS,” the authors wrote. “Improvement of 2 or more points in pain may be an indication that a patient is ...

The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ulcerative pyoderma gangrenosum (PG), a rare skin disorder characterized by chronic ...

Phase 3 pyoderma gangrenosum trial was halted after analysis of 30 patients showed no efficacy signal. InflaRx to prioritize INF904 with key data expected in chronic spontaneous urticaria and ...

In a recently published systematic review, researchers determined that VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome typically presents in men, with atypical morphology ...

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

This research is significant as Humira is the only approved treatment for Pyoderma Gangrenosum in Japan. The study tested Humira (Adalimumab), an injectable medication, on approximately 60 ...

SPOKANE, Wash. – Ryan Becker, a Spokane resident, is battling an extremely rare skin condition known as pyoderma gangrenosum. After visits to the Mayo Clinic and Johns Hopkins, Becker has been ...